Samumed completes phase I chronic tendinopathy study

13:10 EDT 24 Jul 2017 | CentreWatch

Samumed, a leader in musculoskeletal conditions, announced the successful completion of a phase I clinical trial in healthy subjects for its potential treatment of chronic tendinopathy, a degenerative and fibrotic condition caused by injuries or overuse and that has no FDA-approved drug treatments today. The study results supported the continuation of the program into future […]

The post Samumed completes phase I chronic tendinopathy study appeared first on CenterWatch News Online.

Original Article: Samumed completes phase I chronic tendinopathy study


More From BioPortfolio on "Samumed completes phase I chronic tendinopathy study"

Quick Search


Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...